(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors

Mark J. Bamford, Michael J. Alberti, Nicholas Bailey, Susannah Davies, David K. Dean, Alessandra Gaiba, Stephen L. Garland, John D. Harling, David Jung, Terence A. Panchal,

Bioorganic & Medicinal Chemistry Letters · 2005 · 43 citations · 9 references

DOIFull text

Open access

Concepts

References

9